tiprankstipranks
Relmada Therapeutics (DE:4E2)
STUTTGART:4E2

Relmada Therapeutics (4E2) Balance Sheet

0 Followers

Relmada Therapeutics Balance Sheet

Relmada Therapeutics's total assets for Q4 2023 were $97.55M, a decrease of -10.62% from the previous quarter. DE:4E2 total liabilities were $12.19M for the fiscal quarter, a 44.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Jun 19
Total Assets
$ 97.55M$ 152.91M$ 223.33M$ 118.19M$ 10.22M
Total Liabilities
$ 12.19M$ 12.47M$ 15.06M$ 12.60M$ 2.61M
Total Equity Gross Minority
$ 85.36M$ 140.44M$ 208.26M$ 105.58M$ 7.61M
Total Capitalization
$ 85.36M$ 140.44M$ 208.26M$ 105.58M$ 7.61M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Relmada Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis